Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases

US Patent 11845808 · Granted Dec 19, 2023

Estimated economic value: $136,773,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Lipidated peptide inhibitors of interleukin-23 receptor2025
Hepcidin analogues and uses thereof2025
Hepcidin analogues and uses thereof2025
Conjugated hepcidin mimetics2025
Conjugated hepcidin mimetics2025
Conjugated hepcidin mimetics2025
Immunoglobulins and uses thereof2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammator2024